Login to Your Account



Neuron-Saving Ganglioside Drug Seeks 150 Parkinson Patients To Sign Up For Phase II Study


Tuesday, July 27, 1999
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription